Table 2.

Prediction of composite cardiac events in patients with NICM (model 1)

	HR (95 % CIs)	p-value
Multiple LGE lesions	11.4 (1.5–92.0)	0.020
NYHA ≥ III	0.77 (0.16–4.2)	0.756
BNP	0.997 (0.994–0.999)	0.017
Creatinine	81 (6–1122)	0.001
Furosemide	7.4 (0.9–68.3)	0.067
LGE size	1.9 (0.1–34.7)	0.658
LVESV	0.991 (0.970–1.013)	0.429
LVEF	0.995 (0.887–1.116)	0.925

BNP brain natriuretic peptide, CIs confidence intervals, HR hazard ratio, LGE late gadolinium enhancement, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, NICM non-ischemic cardiomyopathy, NYHA New York Heart Association classification